| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +24.28% | +0.46% | +23.82% | +23.82% | — |
| 14d | 2 | +0.00% | +18.29% | +2.19% | +16.09% | +16.09% | — |
| 30d | 2 | +100.00% | -36.30% | +0.86% | -37.16% | -37.16% | — |
| 60d | 2 | +100.00% | -28.83% | +3.90% | -32.74% | -32.74% | — |
| 90d | 2 | +100.00% | -49.88% | +2.42% | -52.30% | -52.30% | — |
| 180d | 2 | +100.00% | -70.74% | +11.51% | -82.25% | -82.25% | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,000 | — | — | 14,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 84,200 | — | — | 84,200 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,788 | $26.37 | $152.6K | 4,733 | Nov 17, 2025 | Nov 19, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 10,000 | $2.08 | $20.8K | 14,733 | Nov 17, 2025 | Nov 19, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,212 | $25.74 | $108.4K | 10,521 | Nov 17, 2025 | Nov 19, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | SALE Chief Commercial Officer | 10,000 | — | — | 53,241 | Nov 17, 2025 | Nov 19, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 1,400 | $2.08 | $2.9K | 4,733 | Apr 9, 2025 | Apr 9, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | SALE Chief Commercial Officer | 1,400 | — | — | 63,241 | Apr 9, 2025 | Apr 9, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,100 | — | — | 80,100 | Jan 9, 2025 | Jan 13, 2025 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 3,333 | $2.08 | $6.9K | 3,333 | Dec 16, 2024 | Dec 17, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | SALE Chief Commercial Officer | 3,333 | — | — | 64,641 | Dec 16, 2024 | Dec 17, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 105,000 | — | — | 105,000 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,915 | — | — | 50,915 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 30,466 | — | — | 30,466 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| LENZ LENZ THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 67,974 | — | — | 67,974 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |